Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Schuth Alexander O.. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Schuth Alexander O. har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:DNLI / Denali Therapeutics Inc. COFO and Secretary 242.346
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Schuth Alexander O.. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Schuth Alexander O. som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-08-14 2025-08-12 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.937 242.346 -1,20 13,58 -39.884 3.291.059
2025-01-08 2025-01-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.907 244.308 -1,18 20,81 -60.495 5.084.049
2025-01-08 2025-01-06 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -12.255 247.215 -4,72 20,22 -247.796 4.998.687
2025-01-07 2025-01-03 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 54.180 259.470 26,39
2024-12-31 2024-12-27 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 6.708 205.290 3,38 5,28 35.418 1.083.931
2024-11-26 2024-11-22 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 20.516 198.582 11,52 0,68 13.951 135.036
2024-11-12 2024-11-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -300 178.066 -0,17 31,29 -9.387 5.571.685
2024-11-12 2024-11-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.925 178.366 -1,61 30,72 -89.856 5.479.404
2024-11-12 2024-11-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -12.333 181.291 -6,37 29,68 -366.043 5.380.717
2024-11-12 2024-11-07 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 15.558 193.624 8,74 5,28 82.146 1.022.335
2024-08-22 2024-08-21 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.547 178.066 -1,41 24,78 -63.115 4.412.475
2024-08-22 2024-08-20 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.353 180.613 -1,82 23,54 -78.930 4.251.630
2024-08-22 2024-08-20 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.453 183.966 -1,32 23,79 -58.357 4.376.551
2024-08-15 2024-08-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.272 186.419 -1,20 22,89 -52.006 4.267.131
2024-02-15 2024-02-14 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -20.128 187.341 -9,70 17,66 -355.460 3.308.442
2024-02-15 2024-02-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.716 207.469 -1,29 17,29 -46.960 3.587.139
2024-02-12 2024-02-08 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 50.000 210.185 31,21 0,68 34.000 142.926
2024-01-09 2024-01-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -9.972 539.307 -1,82 19,43 -193.756 10.478.735
2024-01-05 2024-01-03 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 53.720 170.157 46,14
2023-08-25 2023-08-23 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.522 518.989 -0,48 23,17 -58.435 12.024.975
2023-08-23 2023-08-21 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.478 521.511 -0,47 22,59 -55.978 11.780.933
2023-08-16 2023-08-14 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.772 518.989 -0,53 23,67 -65.613 12.284.470
2023-08-14 2023-08-10 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.853 521.761 -0,54 24,18 -68.986 12.616.181
2023-07-19 2023-07-18 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -9.702 518.989 -1,84 30,01 -291.157 15.574.860
2023-07-19 2023-07-17 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -10.000 528.691 -1,86 29,60 -296.000 15.649.254
2023-07-19 2023-07-17 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 10.000 538.691 1,89 5,28 52.800 2.844.288
2023-05-17 2023-05-15 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -800 528.691 -0,15 29,23 -23.384 15.453.638
2023-05-17 2023-05-15 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -9.200 529.491 -1,71 28,55 -262.660 15.116.968
2023-05-17 2023-05-15 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 10.000 538.691 1,89 5,28 52.800 2.844.288
2023-04-14 2023-04-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -4.898 528.691 -0,92 25,04 -122.646 13.238.423
2023-04-14 2023-04-13 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 4.898 533.589 0,93 5,28 25.861 2.817.350
2023-04-14 2023-04-12 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -5.102 528.691 -0,96 25,04 -127.754 13.238.423
2023-04-14 2023-04-12 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 5.102 533.793 0,97 5,28 26.939 2.818.427
2023-02-15 2023-02-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -3.497 528.691 -0,66 30,09 -105.225 15.908.312
2023-02-15 2023-02-13 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 25.000 524.902 5,00 0,68 17.000 356.933
2023-02-10 2023-02-08 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -1.521 499.902 -0,30 30,89 -46.984 15.441.973
2023-01-19 2023-01-17 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -114 497.173 -0,02 29,87 -3.405 14.850.558
2023-01-19 2023-01-17 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -9.886 497.287 -1,95 29,53 -291.934 14.684.885
2023-01-19 2023-01-17 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 10.000 507.173 2,01 5,28 52.800 2.677.873
2023-01-09 2023-01-04 4/A DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.912 492.309 -0,59 28,70 -83.574 14.129.268
2023-01-09 2023-01-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.636 497.173 -0,53 28,44 -74.968 14.139.600
2023-01-05 2023-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.912 149.828 -1,91 28,70 -83.574 4.300.064
2023-01-05 2023-01-03 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 41.120 157.578 35,31
2022-10-12 2022-10-07 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 20.000 487.471 4,28 0,68 13.600 331.480
2022-08-23 2022-08-19 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.576 467.471 -0,55 33,22 -85.575 15.529.387
2022-08-11 2022-08-09 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 22.500 121.458 22,74
2022-02-15 2022-02-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.803 465.047 -0,60 34,68 -97.208 16.127.830
2022-02-11 2022-02-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -1.423 460.564 -0,31 37,10 -52.800 17.088.997
2022-01-07 2022-01-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.846 457.737 -0,62 44,77 -127.415 20.492.885
2022-01-05 2022-01-03 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 93.000 93.000
2022-01-05 2022-01-03 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 31.000 117.454 35,86
2021-12-08 2021-12-06 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -7.200 453.083 -1,56 42,45 -305.640 19.233.373
2021-12-08 2021-12-06 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.800 460.283 -0,60 41,82 -117.096 19.249.035
2021-11-08 2021-11-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.283 463.083 -0,70 53,23 -174.754 24.649.908
2021-11-08 2021-11-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -6.717 466.366 -1,42 52,65 -353.650 24.554.170
2021-10-06 2021-10-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -4.006 473.083 -0,84 51,04 -204.466 24.146.156
2021-10-06 2021-10-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -5.994 477.089 -1,24 50,24 -301.139 23.968.951
2021-09-22 2021-09-20 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise -9.045 240.078 -3,63
2021-09-22 2021-09-20 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 9.045 95.499 10,46 0,68 6.151 64.939
2021-09-09 2021-09-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.441 474.038 -0,51 56,05 -136.818 26.569.830
2021-09-09 2021-09-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -5.350 476.479 -1,11 55,67 -297.834 26.525.586
2021-09-09 2021-09-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.209 481.829 -0,46 54,70 -120.832 26.356.046
2021-08-23 2021-08-19 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -196 484.038 -0,04 50,10 -9.820 24.250.304
2021-08-23 2021-08-19 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.348 484.234 -0,48 49,56 -116.367 23.998.637
2021-08-06 2021-08-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -200 481.582 -0,04 52,99 -10.598 25.519.030
2021-08-06 2021-08-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -8.236 481.782 -1,68 52,34 -431.064 25.215.988
2021-08-06 2021-08-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.564 490.018 -0,32 51,52 -80.571 25.243.767
2021-07-08 2021-07-06 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -10.000 491.582 -1,99 76,20 -762.040 37.460.515
2021-06-08 2021-06-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -4.340 501.582 -0,86 64,82 -281.301 32.510.539
2021-06-08 2021-06-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -5.660 505.922 -1,11 64,35 -364.198 32.554.057
2021-05-06 2021-05-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -445 511.582 -0,09 57,39 -25.539 29.359.691
2021-05-06 2021-05-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.557 512.027 -0,69 55,92 -198.890 28.629.990
2021-05-06 2021-05-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -5.998 515.584 -1,15 55,09 -330.436 28.404.038
2021-04-06 2021-04-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -700 521.582 -0,13 57,44 -40.206 29.958.105
2021-04-06 2021-04-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -4.156 522.282 -0,79 56,46 -234.669 29.490.653
2021-04-06 2021-04-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -5.144 526.438 -0,97 55,60 -286.027 29.272.059
2021-03-04 2021-03-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.878 531.582 -0,35 61,58 -115.647 32.734.820
2021-03-04 2021-03-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -8.122 533.460 -1,50 60,89 -494.524 32.480.779
2021-02-16 2021-02-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -433 541.582 -0,08 71,41 -30.920 38.673.287
2021-02-16 2021-02-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.614 542.015 -0,48 70,17 -183.422 38.032.651
2021-02-11 2021-02-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -206 537.344 -0,04 75,68 -15.591 40.668.343
2021-02-11 2021-02-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -1.262 537.550 -0,23 74,66 -94.218 40.132.408
2021-02-11 2021-02-07 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
M - Exercise -4.250 8.500 -33,33
2021-02-11 2021-02-07 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 4.250 538.812 0,80
2021-02-05 2021-02-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.912 534.562 -0,36 68,61 -131.180 36.675.764
2021-02-05 2021-02-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -6.509 536.474 -1,20 67,90 -441.942 36.424.975
2021-02-05 2021-02-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.579 542.983 -0,29 66,65 -105.239 36.189.274
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 90.000 90.000
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 30.000 30.000
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.226 544.562 -0,22 84,17 -103.190 45.834.912
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.900 545.788 -0,35 82,96 -157.631 45.280.646
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -7.996 547.688 -1,44 82,14 -656.767 44.985.449
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.817 555.684 -0,50 81,45 -229.433 45.258.072
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.598 558.501 -0,64 79,78 -287.062 44.559.388
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -7.876 562.099 -1,38 78,42 -617.675 44.082.614
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.472 569.975 -0,26 77,64 -114.287 44.253.201
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -980 571.447 -0,17 76,41 -74.877 43.661.579
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -700 572.427 -0,12 75,61 -52.924 43.278.744
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -5.144 573.127 -0,89 74,01 -380.698 42.416.098
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -4.626 578.271 -0,79 73,09 -338.101 42.264.208
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -8.531 582.897 -1,44 72,22 -616.094 42.095.830
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -9.709 591.428 -1,62 71,03 -689.652 42.010.432
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -9.340 601.137 -1,53 70,10 -654.738 42.139.944
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.067 610.477 -0,17 69,07 -73.701 42.167.600
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -518 611.544 -0,08 67,78 -35.110 41.449.841
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.100 612.062 -0,18 66,58 -73.234 40.748.885
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.400 613.162 -0,23 65,17 -91.233 39.957.560
2020-11-30 2020-08-21 4/A DNLI Denali Therapeutics Inc.
Common Stock
F - Taxes -1.954 614.562 -0,32 32,88 -64.248 20.206.799
2020-11-30 2020-08-20 4/A DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 5.643 616.516 0,92
2020-08-24 2020-08-21 4 DNLI Denali Therapeutics Inc.
Common Stock
F - Taxes -1.954 614.562 -0,32 32,88 -64.248 20.206.799
2020-08-24 2020-08-20 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
M - Exercise -5.643 0 -100,00
2020-08-24 2020-08-20 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 5.643 616.516 0,92
2020-08-20 2020-08-18 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 20.000 20.000
2020-04-01 2020-03-30 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -1.427 28.662 -4,74 19,49 -27.812 558.622
2020-04-01 2020-02-07 4/A DNLI Denali Therapeutics Inc.
Restricted Stock Units
M - Exercise -4.250 12.750 -25,00
2020-04-01 2020-02-07 4/A DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 4.250 30.089 16,45
2020-02-12 2020-02-10 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 136.000 136.000
2020-02-12 2020-02-10 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 29.143 29.143
2019-12-05 2019-12-04 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise -3.121 108.937 -2,79
2019-12-05 2019-12-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.121 25.839 -10,78 18,00 -56.178 465.102
2019-12-05 2019-12-04 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 3.121 28.960 12,08 5,28 16.479 152.909
2019-12-05 2019-12-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.656 580.710 -0,46 18,00 -47.808 10.452.780
2019-12-05 2019-12-03 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise -711 112.058 -0,63
2019-12-05 2019-12-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -711 25.839 -2,68 18,01 -12.805 465.360
2019-12-05 2019-12-03 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 711 26.550 2,75 5,28 3.754 140.184
2019-12-05 2019-12-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.012 583.366 -0,17 18,01 -18.226 10.506.422
2019-11-26 2019-11-26 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -229 584.378 -0,04 18,02 -4.127 10.530.492
2019-11-26 2019-11-25 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -14.125 584.607 -2,36 18,02 -254.532 10.534.618
2019-11-26 2019-11-22 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -646 598.732 -0,11 18,00 -11.628 10.777.176
2019-10-25 2019-10-23 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise -5.129 112.769 -4,35
2019-10-25 2019-10-23 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 5.129 25.839 24,77 5,28 27.081 136.430
2019-09-11 2019-09-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -7.500 610.089 -1,21 18,16 -136.200 11.079.216
2019-08-22 2019-08-21 4 DNLI Denali Therapeutics Inc.
Common Stock
F - Taxes -1.975 20.710 -8,71 18,60 -36.731 385.160
2019-08-22 2019-08-20 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
M - Exercise -5.643 5.643 -50,00
2019-08-22 2019-08-20 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 5.643 22.685 33,11
2019-08-09 2019-08-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -7.500 617.589 -1,20 18,81 -141.075 11.616.849
2019-07-10 2019-07-08 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -400 625.089 -0,06 20,90 -8.360 13.064.360
2019-07-10 2019-07-08 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -7.100 625.489 -1,12 20,25 -143.775 12.666.152
2019-06-12 2019-06-10 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -7.500 632.589 -1,17 18,77 -140.775 11.873.696
2019-05-13 2019-05-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.500 640.089 -0,39 21,09 -52.725 13.499.477
2019-05-13 2019-05-10 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.500 642.589 -0,39 22,19 -55.475 14.259.050
2019-05-13 2019-05-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.500 645.089 -0,39 22,86 -57.150 14.746.735
2019-04-11 2019-04-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.512 647.589 -0,39 27,73 -69.658 17.957.643
2019-04-11 2019-04-10 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.513 650.101 -0,39 28,26 -71.017 18.371.854
2019-04-11 2019-04-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.475 652.614 -0,38 28,17 -69.721 18.384.136
2019-03-13 2019-03-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.512 655.089 -0,23 24,33 -36.787 15.938.315
2019-03-13 2019-03-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.000 656.601 -0,15 23,60 -23.600 15.495.784
2019-03-13 2019-03-12 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.513 657.601 -0,38 22,40 -56.291 14.730.262
2019-03-13 2019-03-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -275 660.114 -0,04 21,80 -5.995 14.390.485
2019-03-13 2019-03-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.200 660.389 -0,33 21,20 -46.640 14.000.247
2019-02-12 2019-02-12 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.700 662.589 -0,26 20,24 -34.408 13.410.801
2019-02-12 2019-02-12 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -800 664.289 -0,12 19,73 -15.784 13.106.422
2019-02-12 2019-02-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.266 665.089 -0,19 19,35 -24.497 12.869.472
2019-02-12 2019-02-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.234 666.355 -0,18 18,74 -23.125 12.487.493
2019-02-12 2019-02-08 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.500 667.589 -0,37 18,11 -45.275 12.090.037
2019-02-11 2019-02-07 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 136.000 136.000
2019-02-11 2019-02-07 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 17.000 17.000
2019-01-11 2019-01-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.500 670.089 -0,37 20,80 -52.000 13.937.851
2019-01-11 2019-01-10 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.500 672.589 -0,37 19,99 -49.975 13.445.054
2019-01-11 2019-01-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.500 675.089 -0,37 20,31 -50.775 13.711.058
2018-12-12 2018-12-12 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.500 677.589 -0,37 20,80 -52.000 14.093.851
2018-12-12 2018-12-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.500 680.089 -0,37 20,22 -50.550 13.751.400
2018-12-12 2018-12-10 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.500 682.589 -0,36 20,18 -50.450 13.774.646
2018-10-03 2018-10-02 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise -5.859 56.641 -9,37
2018-10-03 2018-10-02 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise -1.184 117.898 -0,99
2018-10-03 2018-10-02 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 5.859 12.961 82,50 9,60 56.246 124.426
2018-10-03 2018-10-02 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 1.184 7.102 20,01 5,28 6.252 37.499
2018-08-22 2018-08-20 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 11.286 11.286
2018-06-26 2018-06-22 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise -5.918 119.082 -4,73
2018-06-26 2018-06-22 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 5.918 5.918 5,28 31.247 31.247
2018-02-28 2018-02-26 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 180.000 180.000
2017-12-07 3 DNLI Denali Therapeutics Inc.
Common Stock
1.370.178
2017-12-07 3 DNLI Denali Therapeutics Inc.
Common Stock
1.370.178
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)